1983
DOI: 10.1016/0039-6257(83)90152-2
|View full text |Cite
|
Sign up to set email alerts
|

Laboratory and clinical studies on the mechanism of action of timolol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

1988
1988
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(12 citation statements)
references
References 23 publications
0
11
0
1
Order By: Relevance
“…This suggests that: (a) concentrations of betaxolol in the eye may be sufficient to block ciliary ~2-receptors (Lesar 1987) and/or (b) ocular ~2-receptors differ from those in other tissues (Lesar 1987;Lotti et al 1984;Neufeld et al 1983). It was not the intention to imply that betaxolol acts solely via specific blockade of ~2-receptors in the management of glaucoma.…”
Section: Discussionmentioning
confidence: 96%
“…This suggests that: (a) concentrations of betaxolol in the eye may be sufficient to block ciliary ~2-receptors (Lesar 1987) and/or (b) ocular ~2-receptors differ from those in other tissues (Lesar 1987;Lotti et al 1984;Neufeld et al 1983). It was not the intention to imply that betaxolol acts solely via specific blockade of ~2-receptors in the management of glaucoma.…”
Section: Discussionmentioning
confidence: 96%
“…However, reviews (1,2,3) and recent publications (4,5,6) indicate that the actual mechanism of these agents for reducing IOP has not yet been described. In 1991, Whikehart et al (7) reported the inhibition of plasma membrane Na,K-ATPase (E.C.…”
Section: Introductionmentioning
confidence: 94%
“…Il en résulte une baisse de la formation d'AMP-cyclique nécessaire au transport ionique par les cellules de l'épithélium ciliaire non pigmenté, avec une diminution de la sécrétion active d'HA (Bartels et al 1980). Les ␤ bloquants réduisent également la perfusion des capillaires des procès ciliaires avec une diminution de l'ultrafiltration de l'HA (Zimmermann et al 1977 ;Neufeld et al, 1983). Depuis 1978, ces molécules ont constitué une avancée majeure dans le traitement du glaucome primaire à angle ouvert chez l'homme.…”
Section: Sympatholytiques ␤ (␤ Bloquants)unclassified